About Accessible Diagnostics
Accessible Diagnostics is a company based in Greenville (United States) founded in 2014 by John Warner and Delphine Dean. It operates as a B2C. Accessible Diagnostics has raised $548.5 thousand across 4 funding rounds from investors including SCRA. Accessible Diagnostics operates in a competitive market with competitors including Heska, Viome Life Sciences, Biotangents, Proteomics International and Pictor, among others.
- Headquarter Greenville, United States
- Founders John Warner, Delphine Dean
- SectorsHealthcare
- Website accessiblediagnostics.com
- Legal Name Accessible Diagnostics Llc
- Total Equity Funding$548.5K (USD)
in 4 rounds
- Latest Funding Round$219K (USD), Seed
Oct 2019
- Investors
Funding Insights of Accessible Diagnostics
Accessible Diagnostics has successfully raised a total of $548.5K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $219 thousand completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $548,500
- Total Rounds 4
- Last Round Seed — $219,000
- First Round $50,000
(Jun 2017)
- Investors Count 1
All 4 funding rounds of Accessible Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Accessible Diagnostics
Accessible Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SCRA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are accelerated across sectors by SCRA. | 1983 | scra.org | United States |
Investor details for Accessible Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Accessible Diagnostics
2 people are tracked at Accessible Diagnostics (2 in leadership).
| Name | Role | Group |
|---|---|---|
John Warner | Co-Founder, CEO | Leadership |
Delphine Dean | Co-Founder | Leadership |
Complete people profiles for Accessible Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Accessible Diagnostics
3 dated milestones of Accessible Diagnostics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Accessible Diagnostics is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Seed, of $219K.
Competitors of Accessible Diagnostics
Accessible Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heska, Viome Life Sciences, Biotangents, Proteomics International and Pictor, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heska.com | 1988 | Fort Collins, United States | $6.5M | 361 | Provider of diagnostic solutions for pet care | |
| viomelifesciences.com | 2016 | Bothell, United States | $92.44M | 136 | Provider of tests to prevent, treat, and cure chronic diseases, and cancer | |
| biotangents.co.uk | 2015 | Edinburgh, United Kingdom | $5.62M | 13 | Veterinary diagnostics products are developed for bovine viral diarrhea testing. | |
| proteomics.com.au | 2001 | Perth, Australia | – | – | Medical technology company at the forefront of predictive diagnostics and bio-analytical services | |
| pictordx.com | 2005 | Auckland, New Zealand | $11.1M | – | Immunodiagnostic products are developed via multiplexed assays. | |
| tethysbio.com | 2002 | Emeryville, United States | $53.3M | 81 | Develops biological markers for medical diagnostic applications. | |
| vetevo.de | 2016 | Berlin, Germany | – | 39 | Diagnostic services for pets are booked online with results delivered. | |
| mellitusllc.com | 2011 | Boston, United States | $16.1M | – | In vitro diagnostic test for Gestational Diabetes Mellitus (GDM) | |
| smzyme.com | 2013 | Herzliya Pituach, Israel | $4M | – | Proprietary protein engineering technology is developed for diabetes products. | |
| fluxergy.com | 2011 | Irvine, United States | – | 74 | Provides diagnostic devices and software for clinical and veterinary point-of-care testing. |
Detailed competitors of Accessible Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Accessible Diagnostics
10 companies that operate in the same segment as Accessible Diagnostics (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accessible Diagnostics
Accessible Diagnostics was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Accessible Diagnostics is headquartered in Greenville, United States.
John Warner is the current CEO of Accessible Diagnostics. They have also founded this company.
Accessible Diagnostics is a funded company, having raised a total of $548.5K across 4 funding rounds to date. The company's 1st funding round was a Grant of $50K, raised on Jun 2017.
Accessible Diagnostics delivers comprehensive glucose monitoring device solutions, focusing on providing healthcare solutions, developing medical devices, diagnostic tools, and glucose monitoring. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Accessible Diagnostics's top competitors include Viome Life Sciences, Biotangents and Pictor.
Accessible Diagnostics has 1 investor. Key investors include SCRA.
Accessible Diagnostics operates through Accessible Diagnostics Llc.